Week of March 14, 2023 | Vol. 12, Issue 10

Linkedin  

In This Issue

Upcoming Events

Industry M&A Activity

Recent Transactions

Trading Comps

Market Reports

M&A Pipeline

Featured Headlines

Tanner Updates



Quick Links

Who We Are

M&A Discussion Group

Daybreak Consumer Care

Carlin Consumer Health


Contact Information

Xan Smith

Managing Director

Business Development

xsmith@bourne-partners.com


Jeremy C. Johnson

Managing Director

Head of M&A and Capital Advisory

jjohnson@bourne-partners.com

Industry Snapshot
Above is an overview of recent industry M&A activity. Click on the chart to view complete transaction tables broken out by industry sub sectors. For additional information, see the Industry M&A Activity section below.
Events Hosted or Attended by Bourne Partners

CHPA 2023

March 19-21, 2023 - Orlando, FL

DCAT Week 2023

March 20-23, 2023 - New York City, NY

CPHI-North-America-logo-web image
en_bnr_home_global01 image

CPHI North America

April 25-27, 2023 - Philadelphia, PA

INTERPHEX 2023

April 25-27, 2023 - New York City, NY

INDUSTRY M&A ACTIVITY
Recent Transactions, Trading Comps, Market Reports, M&A Pipeline
RECENT TRANSACTIONS
An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

M&A TRANSACTIONS

Pharma & Biotech

7 transactions totaling $173 million


Supplies, Equipment & Services

8 transactions


Healthcare Facilities & Distributors

4 transactions totaling $193 million


Healthcare IT & Managed Care

4 transactions totaling $131 million

PRIVATE PLACEMENTS

Pharma & Biotech

32 transactions totaling $674 million


Supplies, Equipment & Services

23 transactions totaling $273 million


Healthcare Facilities & Distributors

4 transactions


Healthcare IT & Managed Care

11 transactions totaling $78 million

PUBLIC OFFERINGS

Pharma & Biotech

20 transactions totaling $8.2 billion


Supplies, Equipment & Services

9 transactions totaling $331 million


Healthcare Facilities & Distributors

1 transaction totaling $124 million


Healthcare IT & Managed Care

1 transaction

TRADING COMPS

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

MARKET REPORTS
Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A PIPELINE

Representative Current Retained Sell-Side And Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider


Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform


Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product


Project Gateway

Pharma | Sell-Side

Acquisition opportunity of US specialty generics platform and small portfolio

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO


Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 


Project Power Play

Pharma | Buy-Side

Seeking established brands across all therapeutic categories or growth assets in Neurology / CNS


Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

FEATURED HEADLINES

A Sampling of Industry Headlines

Simris Alg ab Signs Partnership Agreement With Lonza Ltd to Promote Its Adc Payload Technology

Globe Newswire - Mar 6, 2023

Genixus™ Expands Manufacturing Capacity to Meet Demand for KinetiX™ RTA Syringes

Business Wire - Mar 7, 2023

Pace Analytical Services Acquires Alpha Analytical Laboratories

Newswire - Mar 7, 2023

Danaher Partners with the University of Pennsylvania's Center for Cellular Immunotherapies to Address Manufacturing Challenges Impacting the Uptake of Cell Therapies

PR Newswire - Mar 7, 2023

Evonik opens new facility for pharmaceutical lipids at site in Hanau, Germany

Evonik - Mar 8, 2023

Creative Medical taps CRO Syneos to run Type 1 diabetes cell therapy study

Fierce Biotech - Mar 9, 2023

GTP Bioways, Texcell Partner to Provide Extended CDMO and CRO Services

Contract Pharma - Mar 9, 2023

Adaptive Research partners with California hospital to expand trial access

Fierce Biotech - Mar 9, 2023

Catalent Expands UpTempo℠ AAV Platform to Accelerate Development of Gene Therapies

Catalent - Mar 9, 2023

Koneksa links with SSI Strategy to advance digital biomarker services

Fierce Biotech - Mar 9, 2023

Shuttle Pharma, UI Pharma Partner to Manufacture Ropidoxuridine

Contract Pharma - Mar 9, 2023

TANNER NEWS

Linkedin  

Our Mission to Improve Lives

Over the last 20 years we’ve been able to positively impact thousands of lives through access to medicine. And our journey is only just beginning. Learn more about who we are and why we do what we do. Watch the video here.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.